-
1 week ago | 
theaustralian.com.au | Robert Gottliebsen |Ellie Dudley |John Ferguson |Greg Sheridan
EBR Systems has applied for a Transitional Pass-Through (TPT) reimbursement scheme for its WISE CRT System through the US Centers for Medicare & Medicaid Services (CMS)The application is for outpatients, following on from a recommendation from the CMS that inpatients be eligible for the New Technology Add-On PaymentThe criteria are the same for both schemes, giving EBR high confidence they will be approved.
-
3 weeks ago | 
theaustralian.com.au | Peta Credlin |Liam Mendes |Yoni Bashan |Greg Sheridan
StockheadRegenerative medicine developer Orthocell (ASX:OCC) has appointed the first four US distributors for its flagship nerve repair product Remplir. The appointments follow FDA clearance for Remplir which landed earlier this month, and Orthocell are expecting first sales in the US very soon. Today, the US' nerve repair market is valued at US$1.6 billion. Orthocell will tap this market through distributors in Michigan, Virginia, Colorado and Indiana.
-
4 weeks ago | 
theaustralian.com.au | Cameron Stewart |Greg Sheridan |Christine Middap |Bernard Salt
Special Report: Chimeric antigen receptor (CAR-T) cell therapy is a rapidly growing frontier in cancer research, with Australian biotech Arovella Therapeutics at the forefront and working to overcome limitations of this promising treatment.
-
1 month ago | 
theaustralian.com.au | Greg Sheridan |Michael McKenna |Lydia Lynch |Henry Ergas
Funding to support Phase III clinical trials for diabetic foot infections and acute bacterial skin and skin structure infectionsPrivate Australian-based investor has subscribed for $5 million shares via a placementA$10.8 million entitlement offer has been launched at $0.28 per shareSpecial Report: Targeting first revenue in 2026, Recce will use new funds of up to $15.8m to support a Phase III registrational topical clinical trial for its diabetic foot infection (DFI) treatment in Indonesia.
-
1 month ago | 
theaustralian.com.au | Janet Albrechtsen |Hilary Rose |Chris Uhlmann |Greg Sheridan
StockheadTylah Tully chats with Mount Hope Mining (ASX:MHM) managing director Fergus Kiley to talk through the company's recently completed ground gravity survey over its namesake project. Eagerly awaiting results, Mount Hope plans to use the data collected to form a maiden drilling program to be completed later in the year. This video was developed in collaboration with Mount Hope Mining, a Stockhead advertiser at the time of publishing.
-
Aug 9, 2024 | 
theaustralian.com.au | Lachlan McKirdy |Chris Uhlmann |Stephen Rice |Greg Sheridan
Friday might have been a rare day without a gold medal for Australia, but the penultimate day of competition still has plenty of athletes vying for a spot on the podium. Our Stingers are looking to create history in their first gold medal match since 2000, while Eileen Cikamatana is one to watch in her first Olympics competing for Australia. We also have to turn our attention to athletics as our women look to go for even more medals in both the track and field.
-
Aug 1, 2024 | 
theaustralian.com.au | Marco Monteverde |Janet Albrechtsen |Greg Sheridan |Benoit Faucon
The A-League season will kick off on October 18 with a grand-final rematch between reigning champions Central Coast and Melbourne Victory as part of a first-round schedule that also includes a Western Sydney Wanderers-Sydney FC derby. The opening round will also feature the A-League debut of expansion outfit Auckland FC, who will host Brisbane Roar at Go Media Stadium on October 19.
-
Jul 29, 2024 | 
theaustralian.com.au | Duncan Evans |Robyn Ironside |Greg Sheridan |Craig Lord
A beloved radio star whose shock breast cancer diagnosis led to a spike in women booking screenings has called in to her regular show to give listeners an update on her sudden battle, revealing she is still a “bit wonky” following an emergency surgery. Ali Clarke, the host of Adelaide’s Mix 102.3 morning show, shocked listeners last week with the revelation she had been diagnosed with breast cancer and would undergo a mastectomy.
-
Jul 27, 2024 | 
theaustralian.com.au | Tyler Maund |Alexi Demetriadi |Greg Sheridan
Peter and Belinda Blanch are now pondering their next target with Lingani, who thundered home to snare the Listed Lightning Stakes (1050m) at Morphettville on Saturday. The sharp filly charged through the field under a smart steer from Dom Tourneur to hold off Group 1 placegetter Kuroyanagi, and it was heart in mouth viewing for trainer Peter Blanch. “She just keeps giving her all. It was a little bit of a watch, wasn’t it?” Blanch said.
-
Jul 27, 2024 | 
theaustralian.com.au | Brad Waters |Alex Demetriadi |Greg Sheridan
I Am Velvet was adamant she would do things the hard way when maintaining her unbeaten record at Caulfield. The Phillip Stokes-trained filly won her first two starts on the turf and synthetic tracks at Pakenham before stepping up to city class in the $175,000 VOBIS Gold Ingot (1400m). The two-year-old always had the measure of the $1.75 favourite Dom in the straight but I Am Velvet ($3.30) refused to go straight, constantly wanting to lay in on the runner-up in the last 200m.
